Trial intelligence / Profile preview

Oral magnesium oxide versus placebo for pain during hysterosalpingography in infertile women

IRCT20120215009014N585Phase 3Completed

Sponsor
Islamic Azad University
Start
Nov 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in female infertility comparing Magnesium oxide with Placebo (2 arms). Primary endpoint: Procedure-related pain during hysterosalpingography. Started Nov 2025; status: completed.

02

Drugs

magnesium oxide
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT20120215009014N585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call